Mesoblast (MESO) Enterprise Value (2015 - 2025)
Mesoblast (MESO) reported Enterprise Value of -$130.0 million for Q4 2025, down 241.78% on a YoY basis from $91.7 million in Q4 2024, and up 19.55% sequentially from -$161.6 million in Q2 2025.
Mesoblast (MESO) Enterprise Value (2015 - 2025) Analysis & Trends
Mesoblast (MESO) has 11 years of Enterprise Value data on file, last reported at -$130.0 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 241.78% year-over-year to -$130.0 million; the trailing twelve-month figure through Dec 2025 stood at -$130.0 million (down 241.78% YoY), and the FY2025 full-year result was -$161.6 million, down 156.59% from the prior year.
- Enterprise Value grew to -$130.0 million in Q4 2025, from -$161.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$38.0 million in Q4 2024 to a low of -$161.6 million in Q2 2025.
- A 5-year average of -$92.4 million and a median of -$77.6 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 55.84% in 2022 and plunged 241.78% in 2025, its largest moves.
- Tracing MESO's Enterprise Value over 5 years: stood at -$94.8 million in 2021, then climbed by 28.71% to -$67.6 million in 2022, then fell by 14.69% to -$77.6 million in 2023, then surged by 50.96% to -$38.0 million in 2024, then sank by 241.78% to -$130.0 million in 2025.
- Business Quant data shows MESO's Enterprise Value at -$130.0 million in Q4 2025, -$161.6 million in Q2 2025, and -$38.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | -129.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -129.98 Mn |
| Jun 30, 2025 | -161.16 Mn |
| Dec 31, 2024 | -38.03 Mn |
| Jun 30, 2024 | -62.96 Mn |
| Dec 31, 2023 | -77.55 Mn |
| Jun 30, 2023 | -71.32 Mn |
| Mar 31, 2023 | -48.80 Mn |
| Dec 31, 2022 | -67.62 Mn |
| Sep 30, 2022 | -85.50 Mn |
| Jun 30, 2022 | -60.45 Mn |
| Mar 31, 2022 | -76.76 Mn |
| Dec 31, 2021 | -94.85 Mn |
| Sep 30, 2021 | -115.96 Mn |
| Jun 30, 2021 | -136.88 Mn |
| Mar 31, 2021 | -158.26 Mn |
| Dec 31, 2020 | -77.53 Mn |
| Sep 30, 2020 | -108.12 Mn |
| Jun 30, 2020 | -129.33 Mn |
| Mar 31, 2020 | -60.08 Mn |
| Dec 31, 2019 | -81.35 Mn |